Search details
1.
Hemolysis After Medication Exposure in Pediatric Patients With G6PD Deficiency.
J Pediatr Hematol Oncol
; 44(5): 261-263, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-34654762
2.
Diagnosis and Management of Pediatric Venous Thromboembolism: New Therapies on the Horizon.
Pediatr Emerg Care
; 37(5): 273-279, 2021 May 01.
Article
in English
| MEDLINE | ID: mdl-33903287
3.
Novel approaches to hemophilia therapy: successes and challenges.
Blood
; 130(21): 2251-2256, 2017 11 23.
Article
in English
| MEDLINE | ID: mdl-29018078
4.
Gene therapy for hemophilia: Progress to date and challenges moving forward.
Transfus Apher Sci
; 58(5): 602-612, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31543256
5.
Iliopsoas hematoma in a patient with sickle cell disease.
Pediatr Blood Cancer
; 65(7): e27040, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29528178
6.
Recurrence of a high-titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis.
Haemophilia
; 27(4): e551-e553, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33866659
7.
A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.
Blood
; 120(12): 2512-20, 2012 Sep 20.
Article
in English
| MEDLINE | ID: mdl-22855607
8.
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life.
Mol Ther Methods Clin Dev
; 32(1): 101205, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38374963
9.
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog.
Mol Ther Methods Clin Dev
; 31: 101159, 2023 Dec 14.
Article
in English
| MEDLINE | ID: mdl-38094200
10.
Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.
J Thromb Haemost
; 21(12): 3477-3489, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37726033
11.
Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.
J Blood Med
; 13: 255-265, 2022.
Article
in English
| MEDLINE | ID: mdl-35592586
12.
B cell-activating factor modulates the factor VIII immune response in hemophilia A.
J Clin Invest
; 131(8)2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33651716
13.
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century.
Mediterr J Hematol Infect Dis
; 12(1): e2020069, 2020.
Article
in English
| MEDLINE | ID: mdl-32952980
14.
Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors.
J Thromb Haemost
; 18(4): 848-852, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31985872
15.
Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients.
J Thromb Haemost
; 17(11): 1838-1847, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31350816
16.
Gene therapy for hemophilia: what does the future hold?
Ther Adv Hematol
; 9(9): 273-293, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-30210756
17.
Emerging therapies for hemophilia: controversies and unanswered questions.
F1000Res
; 72018.
Article
in English
| MEDLINE | ID: mdl-29770199
18.
Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature.
Am J Blood Res
; 4(1): 41-5, 2014.
Article
in English
| MEDLINE | ID: mdl-25232504
19.
Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition.
PLoS One
; 7(10): e48172, 2012.
Article
in English
| MEDLINE | ID: mdl-23144741
Results
1 -
19
de 19
1
Next >
>>